Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Sage Therapeutics, Inc. SAGE |
BLACKROCK INC BLK |
4,425,077 7.200% |
-965,836 (-17.92%) |
Filing History |
| 2025-04-01 5:35 pm Purchase |
2025-03-25 | 13G | Sage Therapeutics, Inc. SAGE |
Madison Avenue International LP | 4,920,763 8.000% |
4,920,763 (New Position) |
Filing History |
| 2025-03-07 10:01 am Sale |
2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 500,915 0.800% |
-3,616,090 (-87.83%) |
Filing History |
| 2025-03-06 4:28 pm Sale |
2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE |
MORGAN STANLEY MS |
1,012,337 1.600% |
-3,530,655 (-77.72%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
RTW Investments, LP | 3,002,370 4.900% |
-2,194,649 (-42.23%) |
Filing History |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 4,117,006 6.700% |
-1,154,102 (-21.89%) |
Filing History |
| 2025-02-05 10:41 am Purchase |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
MORGAN STANLEY MS |
4,542,992 7.400% |
4,542,992 (New Position) |
Filing History |
| 2025-01-31 09:55 am Sale |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 4,838,169 7.900% |
-922,280 (-16.01%) |
Filing History |
| 2025-01-17 06:02 am Sale |
2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 1,178,503 1.900% |
-3,282,190 (-73.58%) |
Filing History |
| 2025-01-10 5:34 pm Unchanged |
2025-01-10 | 13D | Sage Therapeutics, Inc. SAGE |
BIOGEN IDEC INC BIIB |
6,241,473 10.200% |
0 (Unchanged) |
Filing History |
| 2024-11-14 6:14 pm Purchase |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 4,460,693 7.300% |
955,693 (+27.27%) |
Filing History |
| 2024-11-12 4:56 pm Unchanged |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 5,760,449 9.430% |
0 (Unchanged) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,271,108 8.634% |
-1,031,366 (-16.36%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
BLACKROCK INC BLK |
5,390,913 8.800% |
0 (Unchanged) |
Filing History |
| 2024-11-04 3:28 pm Unchanged |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 5,760,449 9.430% |
0 (Unchanged) |
Filing History |
| 2024-11-04 2:10 pm Sale |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 5,760,449 9.430% |
-542,098 (-8.60%) |
Filing History |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
BLACKROCK INC BLK |
5,390,913 8.800% |
727,013 (+15.59%) |
Filing History |
| 2024-10-18 11:37 am Sale |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
STATE STREET CORP STT |
2,926,239 4.800% |
-991,983 (-25.32%) |
Filing History |
| 2024-06-10 12:15 pm Purchase |
2024-05-31 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 6,302,547 10.470% |
983,187 (+18.48%) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 6,302,474 10.472% |
819,997 (+14.96%) |
Filing History |